Michael Madaio to Immunoconjugates
This is a "connection" page, showing publications Michael Madaio has written about Immunoconjugates.
Connection Strength
0.625
-
Human anti-a3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis. Am J Physiol Renal Physiol. 2015 Oct 15; 309(8):F680-4.
Score: 0.497
-
CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice. Autoimmunity. 2004 Sep-Nov; 37(6-7):445-51.
Score: 0.058
-
IFN-a confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice. J Immunol. 2011 Aug 01; 187(3):1506-13.
Score: 0.023
-
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol. 2008 Feb 01; 180(3):1938-47.
Score: 0.018
-
Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus. J Immunol. 2004 Sep 01; 173(5):3524-34.
Score: 0.015
-
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol. 2003 Jul 01; 171(1):489-97.
Score: 0.013